Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Non-cash Items (2023 - 2025)

Historic Non-cash Items for InMed Pharmaceuticals (INM) over the last 3 years, with Q3 2025 value amounting to $50055.0.

  • InMed Pharmaceuticals' Non-cash Items fell 3638.56% to $50055.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $50055.0, marking a year-over-year decrease of 3638.56%. This contributed to the annual value of $72549.0 for FY2025, which is 6068.64% down from last year.
  • InMed Pharmaceuticals' Non-cash Items amounted to $50055.0 in Q3 2025, which was down 3638.56% from $72549.0 recorded in Q2 2025.
  • In the past 5 years, InMed Pharmaceuticals' Non-cash Items ranged from a high of $1.3 million in Q4 2023 and a low of $42297.0 during Q3 2023
  • Over the past 3 years, InMed Pharmaceuticals' median Non-cash Items value was $99006.0 (recorded in 2025), while the average stood at $334758.4.
  • In the last 5 years, InMed Pharmaceuticals' Non-cash Items skyrocketed by 8602.97% in 2024 and then crashed by 9096.73% in 2025.
  • InMed Pharmaceuticals' Non-cash Items (Quarter) stood at $1.3 million in 2023, then plummeted by 89.07% to $136899.0 in 2024, then crashed by 63.44% to $50055.0 in 2025.
  • Its Non-cash Items was $50055.0 in Q3 2025, compared to $72549.0 in Q2 2025 and $99006.0 in Q1 2025.